Canadian Biomass Magazine

Features Biofuel Biofuels
Codexis receives biofuels patent

Mar. 28, 2012, Redwood City, CA - Codexis Inc. has been awarded a key patent from the U.S. Patent and Trademark Office covering an important component of the company’s proprietary enzymatic technology that can be used for production of cellulosic biofuels.


March 28, 2012
By Business Wire

Topics

Mar. 28, 2012, Redwood City, CA – Codexis, Inc., a developer of industrial enzymes to enable
the production of biofuels, biobased chemicals, and pharmaceutical
intermediates, today announced it has been awarded a key patent from the
U.S. Patent and Trademark Office covering an important component of the
company’s proprietary enzymatic technology that can be used for
production of cellulosic biofuels.

Codexis specifically received U.S. Patent No. 8,143,050, “Recombinant
Beta-Glucosidase Variants for Production of Soluble Sugars from
Cellulosic Biomass”.

“This patent covers an enzyme group essential in the conversion of
cellulosic biomass to fermentable sugars, which can subsequently be used
for the production of a wide range of cellulosic biofuels,” said Peter
Strumph, Interim Chief Executive Officer. “This adds to the strong
Codexis intellectual property portfolio already in place and further
strengthens the competitive position in the biofuels market for both
Codexis and Shell, our advanced biofuels development partner.”

This is the latest patent to be added to the company’s portfolio of
intellectual property which also includes patents covering the company’s
CodeXyme™ Cellulase Enzymes and CodeEvolver™ directed evolution
technology platform, among others.

About Codexis, Inc.

Codexis, Inc. is a developer of industrial enzymes to enable the
production of biofuels, biobased chemicals and pharmaceutical
intermediates. Codexis’ product lines include CodeXyme Cellulase
Enzymes and CodeXol Detergent Alcohol. Partners and customers include
global leaders such as Shell, Merck and Pfizer. For more information,
see
www.codexis.com.


Print this page

Related



Leave a Reply

Your email address will not be published. Required fields are marked *

*